You are here

Genentech

Wipeout: Roche's anti-amyloid attack on presymptomatic Alzheimer's ends in failure

Fierce Biotech

Thu, 06/16/22 - 10:40 am

Alzheimer's disease

New Three-Year Data for Genentech’s Evrysdi (risdiplam) Show Long-Term Improvements in Survival and Motor Milestones in Babies With Type 1 Spinal Muscular Atrophy (SMA)

BioSpace

Fri, 04/29/22 - 10:30 am

spinal muscular atrophy

Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar

BioSpace

Thu, 04/14/22 - 10:57 am

bevacizumab-maly

20 years in, Genentech persists and perseveres in Alzheimer's with gantenerumab

Fierce Biotech

Wed, 04/6/22 - 07:44 pm

Alzheimer's disease

JHL's Judas Kiss: an Inside Look at JHL Biotech's Theft from Genentech

BioSpace

Fri, 03/18/22 - 10:44 am

Former CEO And COO Of JHL Biotech Sentenced For Conspiring To Steal Trade Secrets And Commit Wire Fraud Exceeding $101 Million

DOJ

Wed, 03/16/22 - 10:12 am

Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic

Endpoints

Thu, 03/10/22 - 10:27 am

genetic modifiers

Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset

Fierce Biotech

Mon, 12/20/21 - 11:32 pm

Lineage Cell Therapeutics

dry age-related macular degeneration

ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma

Endpoints

Tue, 12/14/21 - 11:12 am

antibody-drug conjugate

Genentech's tocilizumab shortage due to Covid-19 now hits CAR-T recipients, with FDA offering alternatives to help

Endpoints

Mon, 12/13/21 - 11:01 am

ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio

Endpoints

Sun, 12/12/21 - 11:31 pm

bispecific antibodies

Life Sciences Expansions Take Off as 2021 Wraps Up

BioSpace

Thu, 12/9/21 - 10:35 am

Roche Signs Machine-Learning Neuroscience Deal With Recursion

Bloomberg

Tue, 12/7/21 - 10:53 am

artificial intelligence

machine learnings

Recursion Pharmaceuticals

Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer

Xtalks

Wed, 10/27/21 - 10:58 am

ocular implant delivery

macular degeneration

wet age-related macular degeneration

FDA clears Roche’s Susvimo implant for eye disease wet AMD

Pharmaforum

Sun, 10/24/21 - 10:38 pm

wet age-related macular degeneration

Genentech study reveals health equity perception gap between patients and doctors

Fierce Pharma

Mon, 09/27/21 - 11:03 am

racial disparity

After selling to Genentech, the old Jecure team is back at an RNA-focused startup — and more enthusiastic than ever

Endpoints

Tue, 09/21/21 - 10:47 am

Jecure Therapeutics

858 Therapeutics

Biotech's 'founding father' and influential deal broker Fred Frank dies at 89

Endpoints

Mon, 09/13/21 - 10:31 am

Demand for Genentech's Actemra increased 279% from June to August

Beckers Hospital Review

Thu, 08/26/21 - 08:35 pm

monoclonal antibodies

Genentech Hemophilia A Drug Displays Long-term Safety, Efficacy

BioSpace

Mon, 07/19/21 - 11:09 pm

clinical trials

Pages